先天性代謝異常症用医療食品の世界市場インサイト、2029年までの予測Global Medical Foods for Inborn Errors of Metabolism Market Insights, Forecast to 2029 食事療法は、先天性代謝異常の伝統的な方法である。医療用食品とは、医師の指導のもと、特定の病気や症状の食事管理を目的として作られた特殊な食品です。先天性代謝異常とは、代謝に関わるタンパク質をコードす... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー食事療法は、先天性代謝異常の伝統的な方法である。医療用食品とは、医師の指導のもと、特定の病気や症状の食事管理を目的として作られた特殊な食品です。先天性代謝異常とは、代謝に関わるタンパク質をコードする遺伝子の変異による先天的な障害を指す。先天性代謝異常症は、異質な疾患群であり、自然変異により遺伝する可能性が高い。この疾患は通常、炭水化物、タンパク質、脂肪酸などの生体分子の分解または貯蔵に関与する代謝経路の失敗を伴う。先天性代謝異常症向け医療用食品の世界市場は、2023年の100万米ドルから2029年には100万米ドルに達し、予測期間中の複合年間成長率(CAGR)は%と予測されています。 先天性代謝異常症向け医療用食品の米国・カナダ市場は、2023年の100万ドルから2029年には100万ドルに達すると予測され、2023年から2029年の予測期間中にCAGR %で増加すると予測されます。 先天性代謝異常症用医療食品の中国市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年の予測期間中に年平均成長率は%になると予測されます。 先天性代謝異常症用医療食品のヨーロッパ市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年の予測期間中にCAGR %で増加すると予測されます。 先天性代謝異常症用医療食品の世界の主要メーカーは、ネスレ、アボット、レキットベンキーザーグループ、味の素、Solace Nutrition、Primus Pharmaceuticals、BioMarin Pharmaceutical、Danone SAおよびGalen Limitedなどです。2022年、世界の上位5社は、売上高で約 %のシェアを占めています。 レポートには、以下の内容が含まれています: 本レポートでは、先天性代謝異常症向け医療用食品の世界市場の概要、売上、収益、価格などを紹介しています。2018年~2022年の歴史的な市場収益/売上データ、2023年の予測、2029年までのCAGRの予測など、世界市場動向の分析が可能です。 本レポートでは、先天性代謝異常症用メディカルフーズの主要生産者を調査し、主要地域や国の売上も掲載しています。先天性代謝異常用医療食品の今後の市場可能性のハイライトと、この市場を様々なセグメントとサブセグメントに分けて予測するための主要地域/国への注目点です。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データおよび市場価値分析。 本レポートでは、2018年から2023年のデータをもとに、主要メーカーの先天性代謝異常用医療食品の売上、収益、市場シェア、業界ランキングに焦点を当てています。世界の先天性代謝異常用医療食品市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づき分析します。本レポートは、関係者が競争環境を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。 本レポートでは、2018年から2029年までの、タイプ別、用途別のセグメントデータ、売上、収益、価格を分析しています。先天性代謝異常症用医療食品の売上、予測される成長動向、生産技術、用途、エンドユーザー産業の評価と市場規模の予測。 ネスレ、アボット、レキットベンキーザーグループ、味の素、ソラスニュートリション、プリムス製薬、バイオマリン製薬、ダノンSA、ガレンリミテッドなど、世界の主要企業の説明的な企業プロフィール。 会社別 ネスレ アボット レキットベンキーザーグループ 味の素 ソレイユニュートリション プリムス ファーマシューティカルズ バイオマリン・ファーマシューティカル ダノンSA ガレン・リミテッド PKU-MDMIL タイプ別セグメント アミノ酸 GMP含有グリタクチン 鉄分入りアミノ酸調整済み乳児用調製粉乳 低タンパク質食品 その他 アプリケーション別セグメント フェニルケトン尿症(PKU) メイプルシロップ尿症(MSUD) 尿素サイクル障害 腎臓病 その他 地域別セグメント アメリカ・カナダ U.S. カナダ 中国 アジア(中国を除く) 日本 南朝鮮 中国 台湾 東南アジア インド ヨーロッパ ドイツ フランス イギリス イタリア ロシア 中近東、アフリカ、中南米 ブラジル メキシコ トルコ イスラエル GCC諸国 章立て 第1章:報告書のスコープ、市場セグメント別(タイプ別、用途別など)のエグゼクティブサマリー、各市場セグメントの市場規模、将来の発展可能性などを紹介。市場の現状と、短中期および長期的にどのような進化を遂げる可能性があるのかについて、ハイレベルな視点で解説しています。 第2章 先天性代謝異常症用医療食品の世界、地域レベル、国レベルでの販売(消費)、収益。各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来の発展見通し、市場スペース、生産能力などを紹介しています。 第3章:先天性代謝異常用医療食品メーカーの競争環境、価格、売上、収益、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。 第4章:タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、開発可能性をカバーし、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのを助ける。 第5章:読者が異なる下流市場でブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーする、様々な市場セグメントのアプリケーションの分析を提供します。 第6章:米国とカナダ(US & Canada)タイプ別、アプリケーション別、国別、各セグメント別の売上と収益。 第7章:ヨーロッパ(Europe):タイプ別、アプリケーション別、国別、セグメント別の売上高と収益。 第8章:中国 種類別、用途別、国別、各セグメント別の売上と収益。 第9章:アジア(中国を除く) タイプ別、アプリケーション別、地域別、各セグメント別の売上と収益。 第10章:中東、アフリカ、中南米:タイプ別、アプリケーション別、国別、各セグメント別の売上と収益。 第11章:主要メーカーのプロファイルを提供し、製品の説明と仕様、先天性代謝異常用医療食品の売上、収益、価格、粗利益率、最近の開発など、市場の主要企業の基本状況を詳細に紹介する。 第12章:産業チェーン、販売チャネル、主要原材料、流通業者、顧客に関する分析。 第13章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。 第14章:本レポートの要点と結論。 目次1 Study Coverage1.1 Medical Foods for Inborn Errors of Metabolism Product Introduction 1.2 Market by Type 1.2.1 Global Medical Foods for Inborn Errors of Metabolism Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 Amino Acid 1.2.3 Glytactin with GMP 1.2.4 Amino Acid-Modified Infant Formula With Iron 1.2.5 Low Protein Food 1.2.6 Others 1.3 Market by Application 1.3.1 Global Medical Foods for Inborn Errors of Metabolism Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Phenylketonuria (PKU) 1.3.3 Maple Syrup Urine Disease (MSUD) 1.3.4 Urea Cycle Disorders 1.3.5 Renal Disease 1.3.6 Others 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global Medical Foods for Inborn Errors of Metabolism Sales Estimates and Forecasts 2018-2029 2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region 2.2.1 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region: 2018 VS 2022 VS 2029 2.2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region (2018-2023) 2.2.3 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region (2024-2029) 2.2.4 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Region (2018-2029) 2.3 Global Medical Foods for Inborn Errors of Metabolism Sales Estimates and Forecasts 2018-2029 2.4 Global Medical Foods for Inborn Errors of Metabolism Sales by Region 2.4.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Region: 2018 VS 2022 VS 2029 2.4.2 Global Medical Foods for Inborn Errors of Metabolism Sales by Region (2018-2023) 2.4.3 Global Medical Foods for Inborn Errors of Metabolism Sales by Region (2024-2029) 2.4.4 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Region (2018-2029) 2.5 US & Canada 2.6 Europe 2.7 China 2.8 Asia (excluding China) 2.9 Middle East, Africa and Latin America 3 Competition by Manufactures 3.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Manufacturers 3.1.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Manufacturers (2018-2023) 3.1.2 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Manufacturers (2018-2023) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Medical Foods for Inborn Errors of Metabolism in 2022 3.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Manufacturers 3.2.1 Global Medical Foods for Inborn Errors of Metabolism Revenue by Manufacturers (2018-2023) 3.2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Manufacturers (2018-2023) 3.2.3 Global Top 10 and Top 5 Companies by Medical Foods for Inborn Errors of Metabolism Revenue in 2022 3.3 Global Key Players of Medical Foods for Inborn Errors of Metabolism, Industry Ranking, 2021 VS 2022 VS 2023 3.4 Global Medical Foods for Inborn Errors of Metabolism Sales Price by Manufacturers 3.5 Analysis of Competitive Landscape 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.5.2 Global Medical Foods for Inborn Errors of Metabolism Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Key Manufacturers of Medical Foods for Inborn Errors of Metabolism, Manufacturing Base Distribution and Headquarters 3.7 Global Key Manufacturers of Medical Foods for Inborn Errors of Metabolism, Product Offered and Application 3.8 Global Key Manufacturers of Medical Foods for Inborn Errors of Metabolism, Date of Enter into This Industry 3.9 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Type 4.1.1 Global Medical Foods for Inborn Errors of Metabolism Historical Sales by Type (2018-2023) 4.1.2 Global Medical Foods for Inborn Errors of Metabolism Forecasted Sales by Type (2024-2029) 4.1.3 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2018-2029) 4.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Type 4.2.1 Global Medical Foods for Inborn Errors of Metabolism Historical Revenue by Type (2018-2023) 4.2.2 Global Medical Foods for Inborn Errors of Metabolism Forecasted Revenue by Type (2024-2029) 4.2.3 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Type (2018-2029) 4.3 Global Medical Foods for Inborn Errors of Metabolism Price by Type 4.3.1 Global Medical Foods for Inborn Errors of Metabolism Price by Type (2018-2023) 4.3.2 Global Medical Foods for Inborn Errors of Metabolism Price Forecast by Type (2024-2029) 5 Market Size by Application 5.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Application 5.1.1 Global Medical Foods for Inborn Errors of Metabolism Historical Sales by Application (2018-2023) 5.1.2 Global Medical Foods for Inborn Errors of Metabolism Forecasted Sales by Application (2024-2029) 5.1.3 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2018-2029) 5.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Application 5.2.1 Global Medical Foods for Inborn Errors of Metabolism Historical Revenue by Application (2018-2023) 5.2.2 Global Medical Foods for Inborn Errors of Metabolism Forecasted Revenue by Application (2024-2029) 5.2.3 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Application (2018-2029) 5.3 Global Medical Foods for Inborn Errors of Metabolism Price by Application 5.3.1 Global Medical Foods for Inborn Errors of Metabolism Price by Application (2018-2023) 5.3.2 Global Medical Foods for Inborn Errors of Metabolism Price Forecast by Application (2024-2029) 6 US & Canada 6.1 US & Canada Medical Foods for Inborn Errors of Metabolism Market Size by Type 6.1.1 US & Canada Medical Foods for Inborn Errors of Metabolism Sales by Type (2018-2029) 6.1.2 US & Canada Medical Foods for Inborn Errors of Metabolism Revenue by Type (2018-2029) 6.2 US & Canada Medical Foods for Inborn Errors of Metabolism Market Size by Application 6.2.1 US & Canada Medical Foods for Inborn Errors of Metabolism Sales by Application (2018-2029) 6.2.2 US & Canada Medical Foods for Inborn Errors of Metabolism Revenue by Application (2018-2029) 6.3 US & Canada Medical Foods for Inborn Errors of Metabolism Market Size by Country 6.3.1 US & Canada Medical Foods for Inborn Errors of Metabolism Revenue by Country: 2018 VS 2022 VS 2029 6.3.2 US & Canada Medical Foods for Inborn Errors of Metabolism Sales by Country (2018-2029) 6.3.3 US & Canada Medical Foods for Inborn Errors of Metabolism Revenue by Country (2018-2029) 6.3.4 US 6.3.5 Canada 7 Europe 7.1 Europe Medical Foods for Inborn Errors of Metabolism Market Size by Type 7.1.1 Europe Medical Foods for Inborn Errors of Metabolism Sales by Type (2018-2029) 7.1.2 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Type (2018-2029) 7.2 Europe Medical Foods for Inborn Errors of Metabolism Market Size by Application 7.2.1 Europe Medical Foods for Inborn Errors of Metabolism Sales by Application (2018-2029) 7.2.2 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Application (2018-2029) 7.3 Europe Medical Foods for Inborn Errors of Metabolism Market Size by Country 7.3.1 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country: 2018 VS 2022 VS 2029 7.3.2 Europe Medical Foods for Inborn Errors of Metabolism Sales by Country (2018-2029) 7.3.3 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country (2018-2029) 7.3.4 Germany 7.3.5 France 7.3.6 U.K. 7.3.7 Italy 7.3.8 Russia 8 China 8.1 China Medical Foods for Inborn Errors of Metabolism Market Size 8.1.1 China Medical Foods for Inborn Errors of Metabolism Sales (2018-2029) 8.1.2 China Medical Foods for Inborn Errors of Metabolism Revenue (2018-2029) 8.2 China Medical Foods for Inborn Errors of Metabolism Market Size by Application 8.2.1 China Medical Foods for Inborn Errors of Metabolism Sales by Application (2018-2029) 8.2.2 China Medical Foods for Inborn Errors of Metabolism Revenue by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia Medical Foods for Inborn Errors of Metabolism Market Size by Type 9.1.1 Asia Medical Foods for Inborn Errors of Metabolism Sales by Type (2018-2029) 9.1.2 Asia Medical Foods for Inborn Errors of Metabolism Revenue by Type (2018-2029) 9.2 Asia Medical Foods for Inborn Errors of Metabolism Market Size by Application 9.2.1 Asia Medical Foods for Inborn Errors of Metabolism Sales by Application (2018-2029) 9.2.2 Asia Medical Foods for Inborn Errors of Metabolism Revenue by Application (2018-2029) 9.3 Asia Medical Foods for Inborn Errors of Metabolism Sales by Region 9.3.1 Asia Medical Foods for Inborn Errors of Metabolism Revenue by Region: 2018 VS 2022 VS 2029 9.3.2 Asia Medical Foods for Inborn Errors of Metabolism Revenue by Region (2018-2029) 9.3.3 Asia Medical Foods for Inborn Errors of Metabolism Sales by Region (2018-2029) 9.3.4 Japan 9.3.5 South Korea 9.3.6 China Taiwan 9.3.7 Southeast Asia 9.3.8 India 10 Middle East, Africa and Latin America 10.1 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Market Size by Type 10.1.1 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Sales by Type (2018-2029) 10.1.2 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Type (2018-2029) 10.2 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Market Size by Application 10.2.1 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Sales by Application (2018-2029) 10.2.2 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Application (2018-2029) 10.3 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Sales by Country 10.3.1 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Country: 2018 VS 2022 VS 2029 10.3.2 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2018-2029) 10.3.3 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Sales by Country (2018-2029) 10.3.4 Brazil 10.3.5 Mexico 10.3.6 Turkey 10.3.7 Israel 10.3.8 GCC Countries 11 Company Profiles 11.1 Nestlé 11.1.1 Nestlé Company Information 11.1.2 Nestlé Overview 11.1.3 Nestlé Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.1.4 Nestlé Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Nestlé Recent Developments 11.2 Abbott 11.2.1 Abbott Company Information 11.2.2 Abbott Overview 11.2.3 Abbott Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.2.4 Abbott Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Abbott Recent Developments 11.3 Reckitt Benckiser Group 11.3.1 Reckitt Benckiser Group Company Information 11.3.2 Reckitt Benckiser Group Overview 11.3.3 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.3.4 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Reckitt Benckiser Group Recent Developments 11.4 Ajinomoto 11.4.1 Ajinomoto Company Information 11.4.2 Ajinomoto Overview 11.4.3 Ajinomoto Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.4.4 Ajinomoto Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Ajinomoto Recent Developments 11.5 Solace Nutrition 11.5.1 Solace Nutrition Company Information 11.5.2 Solace Nutrition Overview 11.5.3 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.5.4 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Solace Nutrition Recent Developments 11.6 Primus Pharmaceuticals 11.6.1 Primus Pharmaceuticals Company Information 11.6.2 Primus Pharmaceuticals Overview 11.6.3 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.6.4 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Primus Pharmaceuticals Recent Developments 11.7 BioMarin Pharmaceutical 11.7.1 BioMarin Pharmaceutical Company Information 11.7.2 BioMarin Pharmaceutical Overview 11.7.3 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.7.4 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 BioMarin Pharmaceutical Recent Developments 11.8 Danone SA 11.8.1 Danone SA Company Information 11.8.2 Danone SA Overview 11.8.3 Danone SA Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.8.4 Danone SA Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Danone SA Recent Developments 11.9 Galen Limited 11.9.1 Galen Limited Company Information 11.9.2 Galen Limited Overview 11.9.3 Galen Limited Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.9.4 Galen Limited Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Galen Limited Recent Developments 11.10 PKU-MDMIL 11.10.1 PKU-MDMIL Company Information 11.10.2 PKU-MDMIL Overview 11.10.3 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.10.4 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 PKU-MDMIL Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Medical Foods for Inborn Errors of Metabolism Industry Chain Analysis 12.2 Medical Foods for Inborn Errors of Metabolism Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Medical Foods for Inborn Errors of Metabolism Production Mode & Process 12.4 Medical Foods for Inborn Errors of Metabolism Sales and Marketing 12.4.1 Medical Foods for Inborn Errors of Metabolism Sales Channels 12.4.2 Medical Foods for Inborn Errors of Metabolism Distributors 12.5 Medical Foods for Inborn Errors of Metabolism Customers 13 Market Dynamics 13.1 Medical Foods for Inborn Errors of Metabolism Industry Trends 13.2 Medical Foods for Inborn Errors of Metabolism Market Drivers 13.3 Medical Foods for Inborn Errors of Metabolism Market Challenges 13.4 Medical Foods for Inborn Errors of Metabolism Market Restraints 14 Key Findings in The Global Medical Foods for Inborn Errors of Metabolism Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
SummaryDiet therapy is the traditional method of inborn errors of metabolism. Medical food is the specialized food formulated to be consumed under physician supervision and intended for specific dietary management of a particular disease or condition. Inborn errors of metabolism refer to inherited disorders due to mutation in genes coding for proteins functioning in metabolism. The inborn errors of metabolism are a heterogeneous group of disorders and are likely to be inherited through spontaneous mutation. The diseases usually involve failure of metabolic pathways that are either involved in breakdown or storage of biomolecules, such as carbohydrates, proteins, and fatty acids. Table of Contents1 Study Coverage1.1 Medical Foods for Inborn Errors of Metabolism Product Introduction 1.2 Market by Type 1.2.1 Global Medical Foods for Inborn Errors of Metabolism Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 Amino Acid 1.2.3 Glytactin with GMP 1.2.4 Amino Acid-Modified Infant Formula With Iron 1.2.5 Low Protein Food 1.2.6 Others 1.3 Market by Application 1.3.1 Global Medical Foods for Inborn Errors of Metabolism Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Phenylketonuria (PKU) 1.3.3 Maple Syrup Urine Disease (MSUD) 1.3.4 Urea Cycle Disorders 1.3.5 Renal Disease 1.3.6 Others 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global Medical Foods for Inborn Errors of Metabolism Sales Estimates and Forecasts 2018-2029 2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region 2.2.1 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region: 2018 VS 2022 VS 2029 2.2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region (2018-2023) 2.2.3 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region (2024-2029) 2.2.4 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Region (2018-2029) 2.3 Global Medical Foods for Inborn Errors of Metabolism Sales Estimates and Forecasts 2018-2029 2.4 Global Medical Foods for Inborn Errors of Metabolism Sales by Region 2.4.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Region: 2018 VS 2022 VS 2029 2.4.2 Global Medical Foods for Inborn Errors of Metabolism Sales by Region (2018-2023) 2.4.3 Global Medical Foods for Inborn Errors of Metabolism Sales by Region (2024-2029) 2.4.4 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Region (2018-2029) 2.5 US & Canada 2.6 Europe 2.7 China 2.8 Asia (excluding China) 2.9 Middle East, Africa and Latin America 3 Competition by Manufactures 3.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Manufacturers 3.1.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Manufacturers (2018-2023) 3.1.2 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Manufacturers (2018-2023) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Medical Foods for Inborn Errors of Metabolism in 2022 3.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Manufacturers 3.2.1 Global Medical Foods for Inborn Errors of Metabolism Revenue by Manufacturers (2018-2023) 3.2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Manufacturers (2018-2023) 3.2.3 Global Top 10 and Top 5 Companies by Medical Foods for Inborn Errors of Metabolism Revenue in 2022 3.3 Global Key Players of Medical Foods for Inborn Errors of Metabolism, Industry Ranking, 2021 VS 2022 VS 2023 3.4 Global Medical Foods for Inborn Errors of Metabolism Sales Price by Manufacturers 3.5 Analysis of Competitive Landscape 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.5.2 Global Medical Foods for Inborn Errors of Metabolism Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Key Manufacturers of Medical Foods for Inborn Errors of Metabolism, Manufacturing Base Distribution and Headquarters 3.7 Global Key Manufacturers of Medical Foods for Inborn Errors of Metabolism, Product Offered and Application 3.8 Global Key Manufacturers of Medical Foods for Inborn Errors of Metabolism, Date of Enter into This Industry 3.9 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Type 4.1.1 Global Medical Foods for Inborn Errors of Metabolism Historical Sales by Type (2018-2023) 4.1.2 Global Medical Foods for Inborn Errors of Metabolism Forecasted Sales by Type (2024-2029) 4.1.3 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2018-2029) 4.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Type 4.2.1 Global Medical Foods for Inborn Errors of Metabolism Historical Revenue by Type (2018-2023) 4.2.2 Global Medical Foods for Inborn Errors of Metabolism Forecasted Revenue by Type (2024-2029) 4.2.3 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Type (2018-2029) 4.3 Global Medical Foods for Inborn Errors of Metabolism Price by Type 4.3.1 Global Medical Foods for Inborn Errors of Metabolism Price by Type (2018-2023) 4.3.2 Global Medical Foods for Inborn Errors of Metabolism Price Forecast by Type (2024-2029) 5 Market Size by Application 5.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Application 5.1.1 Global Medical Foods for Inborn Errors of Metabolism Historical Sales by Application (2018-2023) 5.1.2 Global Medical Foods for Inborn Errors of Metabolism Forecasted Sales by Application (2024-2029) 5.1.3 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2018-2029) 5.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Application 5.2.1 Global Medical Foods for Inborn Errors of Metabolism Historical Revenue by Application (2018-2023) 5.2.2 Global Medical Foods for Inborn Errors of Metabolism Forecasted Revenue by Application (2024-2029) 5.2.3 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Application (2018-2029) 5.3 Global Medical Foods for Inborn Errors of Metabolism Price by Application 5.3.1 Global Medical Foods for Inborn Errors of Metabolism Price by Application (2018-2023) 5.3.2 Global Medical Foods for Inborn Errors of Metabolism Price Forecast by Application (2024-2029) 6 US & Canada 6.1 US & Canada Medical Foods for Inborn Errors of Metabolism Market Size by Type 6.1.1 US & Canada Medical Foods for Inborn Errors of Metabolism Sales by Type (2018-2029) 6.1.2 US & Canada Medical Foods for Inborn Errors of Metabolism Revenue by Type (2018-2029) 6.2 US & Canada Medical Foods for Inborn Errors of Metabolism Market Size by Application 6.2.1 US & Canada Medical Foods for Inborn Errors of Metabolism Sales by Application (2018-2029) 6.2.2 US & Canada Medical Foods for Inborn Errors of Metabolism Revenue by Application (2018-2029) 6.3 US & Canada Medical Foods for Inborn Errors of Metabolism Market Size by Country 6.3.1 US & Canada Medical Foods for Inborn Errors of Metabolism Revenue by Country: 2018 VS 2022 VS 2029 6.3.2 US & Canada Medical Foods for Inborn Errors of Metabolism Sales by Country (2018-2029) 6.3.3 US & Canada Medical Foods for Inborn Errors of Metabolism Revenue by Country (2018-2029) 6.3.4 US 6.3.5 Canada 7 Europe 7.1 Europe Medical Foods for Inborn Errors of Metabolism Market Size by Type 7.1.1 Europe Medical Foods for Inborn Errors of Metabolism Sales by Type (2018-2029) 7.1.2 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Type (2018-2029) 7.2 Europe Medical Foods for Inborn Errors of Metabolism Market Size by Application 7.2.1 Europe Medical Foods for Inborn Errors of Metabolism Sales by Application (2018-2029) 7.2.2 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Application (2018-2029) 7.3 Europe Medical Foods for Inborn Errors of Metabolism Market Size by Country 7.3.1 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country: 2018 VS 2022 VS 2029 7.3.2 Europe Medical Foods for Inborn Errors of Metabolism Sales by Country (2018-2029) 7.3.3 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country (2018-2029) 7.3.4 Germany 7.3.5 France 7.3.6 U.K. 7.3.7 Italy 7.3.8 Russia 8 China 8.1 China Medical Foods for Inborn Errors of Metabolism Market Size 8.1.1 China Medical Foods for Inborn Errors of Metabolism Sales (2018-2029) 8.1.2 China Medical Foods for Inborn Errors of Metabolism Revenue (2018-2029) 8.2 China Medical Foods for Inborn Errors of Metabolism Market Size by Application 8.2.1 China Medical Foods for Inborn Errors of Metabolism Sales by Application (2018-2029) 8.2.2 China Medical Foods for Inborn Errors of Metabolism Revenue by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia Medical Foods for Inborn Errors of Metabolism Market Size by Type 9.1.1 Asia Medical Foods for Inborn Errors of Metabolism Sales by Type (2018-2029) 9.1.2 Asia Medical Foods for Inborn Errors of Metabolism Revenue by Type (2018-2029) 9.2 Asia Medical Foods for Inborn Errors of Metabolism Market Size by Application 9.2.1 Asia Medical Foods for Inborn Errors of Metabolism Sales by Application (2018-2029) 9.2.2 Asia Medical Foods for Inborn Errors of Metabolism Revenue by Application (2018-2029) 9.3 Asia Medical Foods for Inborn Errors of Metabolism Sales by Region 9.3.1 Asia Medical Foods for Inborn Errors of Metabolism Revenue by Region: 2018 VS 2022 VS 2029 9.3.2 Asia Medical Foods for Inborn Errors of Metabolism Revenue by Region (2018-2029) 9.3.3 Asia Medical Foods for Inborn Errors of Metabolism Sales by Region (2018-2029) 9.3.4 Japan 9.3.5 South Korea 9.3.6 China Taiwan 9.3.7 Southeast Asia 9.3.8 India 10 Middle East, Africa and Latin America 10.1 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Market Size by Type 10.1.1 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Sales by Type (2018-2029) 10.1.2 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Type (2018-2029) 10.2 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Market Size by Application 10.2.1 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Sales by Application (2018-2029) 10.2.2 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Application (2018-2029) 10.3 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Sales by Country 10.3.1 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Country: 2018 VS 2022 VS 2029 10.3.2 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2018-2029) 10.3.3 Middle East, Africa and Latin America Medical Foods for Inborn Errors of Metabolism Sales by Country (2018-2029) 10.3.4 Brazil 10.3.5 Mexico 10.3.6 Turkey 10.3.7 Israel 10.3.8 GCC Countries 11 Company Profiles 11.1 Nestlé 11.1.1 Nestlé Company Information 11.1.2 Nestlé Overview 11.1.3 Nestlé Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.1.4 Nestlé Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Nestlé Recent Developments 11.2 Abbott 11.2.1 Abbott Company Information 11.2.2 Abbott Overview 11.2.3 Abbott Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.2.4 Abbott Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Abbott Recent Developments 11.3 Reckitt Benckiser Group 11.3.1 Reckitt Benckiser Group Company Information 11.3.2 Reckitt Benckiser Group Overview 11.3.3 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.3.4 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Reckitt Benckiser Group Recent Developments 11.4 Ajinomoto 11.4.1 Ajinomoto Company Information 11.4.2 Ajinomoto Overview 11.4.3 Ajinomoto Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.4.4 Ajinomoto Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Ajinomoto Recent Developments 11.5 Solace Nutrition 11.5.1 Solace Nutrition Company Information 11.5.2 Solace Nutrition Overview 11.5.3 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.5.4 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Solace Nutrition Recent Developments 11.6 Primus Pharmaceuticals 11.6.1 Primus Pharmaceuticals Company Information 11.6.2 Primus Pharmaceuticals Overview 11.6.3 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.6.4 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Primus Pharmaceuticals Recent Developments 11.7 BioMarin Pharmaceutical 11.7.1 BioMarin Pharmaceutical Company Information 11.7.2 BioMarin Pharmaceutical Overview 11.7.3 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.7.4 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 BioMarin Pharmaceutical Recent Developments 11.8 Danone SA 11.8.1 Danone SA Company Information 11.8.2 Danone SA Overview 11.8.3 Danone SA Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.8.4 Danone SA Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Danone SA Recent Developments 11.9 Galen Limited 11.9.1 Galen Limited Company Information 11.9.2 Galen Limited Overview 11.9.3 Galen Limited Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.9.4 Galen Limited Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Galen Limited Recent Developments 11.10 PKU-MDMIL 11.10.1 PKU-MDMIL Company Information 11.10.2 PKU-MDMIL Overview 11.10.3 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2018-2023) 11.10.4 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 PKU-MDMIL Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Medical Foods for Inborn Errors of Metabolism Industry Chain Analysis 12.2 Medical Foods for Inborn Errors of Metabolism Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Medical Foods for Inborn Errors of Metabolism Production Mode & Process 12.4 Medical Foods for Inborn Errors of Metabolism Sales and Marketing 12.4.1 Medical Foods for Inborn Errors of Metabolism Sales Channels 12.4.2 Medical Foods for Inborn Errors of Metabolism Distributors 12.5 Medical Foods for Inborn Errors of Metabolism Customers 13 Market Dynamics 13.1 Medical Foods for Inborn Errors of Metabolism Industry Trends 13.2 Medical Foods for Inborn Errors of Metabolism Market Drivers 13.3 Medical Foods for Inborn Errors of Metabolism Market Challenges 13.4 Medical Foods for Inborn Errors of Metabolism Market Restraints 14 Key Findings in The Global Medical Foods for Inborn Errors of Metabolism Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(農産食品)の最新刊レポートQYResearch 社の最新刊レポート本レポートと同じKEY WORD(foods)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/12 10:27 143.85 円 158.71 円 190.22 円 |